Stamford, CT. -- At the American Healthcare Radiology Administrators (AHRA) Annual Meeting and Exhibition, Fujifilm Medical Systems USA, Inc. (Fujifilm) announced the availability of Synapse® version 3.2, its latest PACS software release. With a number of enhancements to existing mammography capabilities, as well as improvements to Fujifilm's patent-pending reading protocol technology, Synapse 3.2 is equipped to address the rapid adoption of digital mammography by providing advanced capabilities for the soft copy interpretation of mammography and other breast imaging studies.

While Synapse always provided multi-modality mammography capabilities, with version 3.2 Fujifilm has further optimized the presentation of images for diagnostic screening by enhancing the visualization and image processing tools. Synapse goes well beyond just the display of mammography images such as by:

-- Integrating CAD into both the technologist and radiologist workflow

-- Enabling the display of CAD markers
-- Providing support for MQSA compliant overlays

Improvements to Fujifilm's patent-pending reading protocol technology also improve the mammography capabilities of Synapse. For instance, reader-specific preferences can be set to provide for efficient and consistent workflows which are critical to the interpretation of all studies, including digital mammography. These user preferences will apply even when FFDM data is integrated into the existing continuum of ultrasound, MR and other breast imaging exams.

"With the rate of adoption of Full Field Digital Mammography systems at an all time high, it's more important than ever to provide facilities with a PACS that has the most advanced capabilities to meet the unique workflow and interpretation needs of breast imaging," said Bob Cooke, Fujifilm's Vice President of Network Business Management. "When you combine the power and innovation of Fujifilm's Synapse PACS with the quality and flexibility of our FCRm FFDM systems, Fujifilm is best prepared to deliver a unique, end-to-end digital solution for any breast imaging facility, large or small," continued Cooke.

Fujifilm has the advantage of combining its leading PACS with a rich, 20+ year history in image processing and proven record of innovation in women's healthcare imaging. An illustration of this is the successful application of its digital x-ray image processing to digital mammography via advancements like Fujifilm's Pattern Enhancement for Mammography (PEM). PEM is a tool for FCRm that detects and improves the conspicuity of minute structural information within the breast, such as micro-calcifications, for images that were acquired with this modality. Particularly with the amount of digital comparisons that emerge from potentially many different acquisition systems, image processing can play a tremendous role in diagnostic breast screening from both a quality and efficiency perspective. With its Synapse PACS, FCRm FFDM system, and advanced image processing capabilities, Fujifilm is uniquely positioned to provide leading digital mammography solutions now and well into the future.

Back to HCB News

More Industry Headlines